Journey Strategic Wealth’s Labcorp LH Stock Holding History

Journey Strategic Wealth’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-736	Closed	-$211K	–	800
2025 Q3	$211K	Buy	+736	New	+$197K	0.01%	644

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Journey Strategic Wealth's LH Position: Q4 2025 in Review

Journey Strategic Wealth sold out of Labcorp (LH) in Q4 2025, closing a stake of 736 shares — an estimated $211K sold.

Journey Strategic Wealth first reported a position in LH in Q3 2025 and held it in 1 quarter. The position peaked at $211K in Q3 2025. 1,025 funds tracked by Wall St. Rank hold LH as of Q4 2025.

Journey Strategic Wealth reported no remaining Labcorp position as of Q4 2025 after selling out during the quarter.
Journey Strategic Wealth sold 736 Labcorp shares in Q4 2025, an estimated $211K.
Journey Strategic Wealth first reported a position in Labcorp in Q3 2025 and held it in 1 quarter.
Journey Strategic Wealth's Labcorp position peaked at $211K in Q3 2025.
1,025 funds tracked by Wall St. Rank held Labcorp as of Q4 2025.

Based on Journey Strategic Wealth's 13F filing for Q4 2025, filed 13 Feb 2026.